1. Home
  2. ACOG vs PHUN Comparison

ACOG vs PHUN Comparison

Compare ACOG & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • PHUN
  • Stock Information
  • Founded
  • ACOG 2000
  • PHUN 2009
  • Country
  • ACOG Canada
  • PHUN United States
  • Employees
  • ACOG N/A
  • PHUN N/A
  • Industry
  • ACOG
  • PHUN EDP Services
  • Sector
  • ACOG
  • PHUN Technology
  • Exchange
  • ACOG Nasdaq
  • PHUN Nasdaq
  • Market Cap
  • ACOG 80.3M
  • PHUN 64.1M
  • IPO Year
  • ACOG N/A
  • PHUN N/A
  • Fundamental
  • Price
  • ACOG $10.69
  • PHUN $3.46
  • Analyst Decision
  • ACOG Strong Buy
  • PHUN Buy
  • Analyst Count
  • ACOG 1
  • PHUN 2
  • Target Price
  • ACOG $20.00
  • PHUN $7.75
  • AVG Volume (30 Days)
  • ACOG 71.5K
  • PHUN 360.3K
  • Earning Date
  • ACOG 08-14-2025
  • PHUN 08-07-2025
  • Dividend Yield
  • ACOG N/A
  • PHUN N/A
  • EPS Growth
  • ACOG N/A
  • PHUN N/A
  • EPS
  • ACOG N/A
  • PHUN N/A
  • Revenue
  • ACOG $2,928,654.00
  • PHUN $2,956,000.00
  • Revenue This Year
  • ACOG N/A
  • PHUN $3.01
  • Revenue Next Year
  • ACOG N/A
  • PHUN $50.72
  • P/E Ratio
  • ACOG N/A
  • PHUN N/A
  • Revenue Growth
  • ACOG N/A
  • PHUN N/A
  • 52 Week Low
  • ACOG $3.75
  • PHUN $2.22
  • 52 Week High
  • ACOG $11.40
  • PHUN $14.60
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • PHUN 60.41
  • Support Level
  • ACOG N/A
  • PHUN $2.95
  • Resistance Level
  • ACOG N/A
  • PHUN $3.10
  • Average True Range (ATR)
  • ACOG 0.00
  • PHUN 0.17
  • MACD
  • ACOG 0.00
  • PHUN 0.03
  • Stochastic Oscillator
  • ACOG 0.00
  • PHUN 93.65

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About PHUN Phunware Inc.

Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.

Share on Social Networks: